. . september 2010 (16) http://lm360.us/Hulsman-son-of-Winsley-from-Kamikawa?Ellrodnei=109 standard life and aviva clash over adviser charging . taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said. . .despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . . . feedback to editors . august 2013 (15) .